Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature Medicine 13, 1133 (2007)
doi:10.1038/nm1007-1133
Reply to 'UK set to reverse stance on research with chimeras'
Richard Hynes1
- Investigator, Howard Hughes Medical Institute, and Daniel K. Ludwig Professor for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA.
e-mail: rohynes@mit.edu
I was very surprised that the news article on chimera research in the UK in your August issue1 contained a number of misuses of the terms 'hybrid' and 'chimera' and failed to distinguish between these two entirely distinct entities. Indeed, in places the article conflated the two terms, which is not helpful in informing the debate about these areas of research.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Opsin activation as a cause of congenital night blindnessNature Neuroscience Article (01 Jul 2003)
